Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Tartour

Showing results (41-50 of 227) with videos related to

Pageof 23
Sort By:
Frontiers in Oncology|April 26, 2014
Control of the immune response by pro-angiogenic factorsThibault Voron, Elie Marcheteau, Simon Pernot, et al.
Cytotherapy|November 28, 2013
Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccinesVirgil Schijns, Eric Tartour, Jaroslav Michalek, et al.
Scientific Reports|June 19, 2026
Importance of the delivery route for the tolerability and efficacy of immunomodulatory agents for lung cancerMarion Ferreira, Aubin Pitiot, Christelle Parent, et al.
Oncoimmunology|March 26, 2013
Trial watch: Cardiac glycosides and cancer therapyLaurie Menger, Erika Vacchelli, Oliver Kepp, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sitesMevyn Nizard, Mariana O Diniz, Helene Roussel, et al.
Cancer Immunology, Immunotherapy : CII|June 21, 2020
The adjuvant effect of melanin is superior to incomplete Freund's adjuvant in subunit/peptide vaccines in miceStefania Cuzzubbo, Claire Banissi, Marie Sophie Rouchon, et al.
FEBS Letters|December 12, 2007
Correlation between Shiga toxin B-subunit stability and antigen crosspresentation: a mutational analysisDavid G Pina, Bahne Stechmann, Valery L Shnyrov, et al.
Frontiers in Immunology|August 14, 2018
Targeting Resident Memory T Cells for Cancer ImmunotherapyCharlotte Blanc, Sophie Hans, Thi Tran, et al.
Oncoimmunology|June 22, 2012
Trial watch: Chemotherapy with immunogenic cell death inducersErika Vacchelli, Lorenzo Galluzzi, Wolf Hervé Fridman, et al.
Oncoimmunology|June 14, 2013
Trial Watch: Adoptive cell transfer for anticancer immunotherapyErika Vacchelli, Alexander Eggermont, Wolf Hervé Fridman, et al.
Pageof 23

Showing results (41-50 of 227) with videos related to

Sort By:
Pageof 23
Frontiers in Oncology|April 26, 2014
Control of the immune response by pro-angiogenic factorsThibault Voron, Elie Marcheteau, Simon Pernot, et al.
Cytotherapy|November 28, 2013
Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccinesVirgil Schijns, Eric Tartour, Jaroslav Michalek, et al.
Scientific Reports|June 19, 2026
Importance of the delivery route for the tolerability and efficacy of immunomodulatory agents for lung cancerMarion Ferreira, Aubin Pitiot, Christelle Parent, et al.
Oncoimmunology|March 26, 2013
Trial watch: Cardiac glycosides and cancer therapyLaurie Menger, Erika Vacchelli, Oliver Kepp, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sitesMevyn Nizard, Mariana O Diniz, Helene Roussel, et al.
Cancer Immunology, Immunotherapy : CII|June 21, 2020
The adjuvant effect of melanin is superior to incomplete Freund's adjuvant in subunit/peptide vaccines in miceStefania Cuzzubbo, Claire Banissi, Marie Sophie Rouchon, et al.
FEBS Letters|December 12, 2007
Correlation between Shiga toxin B-subunit stability and antigen crosspresentation: a mutational analysisDavid G Pina, Bahne Stechmann, Valery L Shnyrov, et al.
Frontiers in Immunology|August 14, 2018
Targeting Resident Memory T Cells for Cancer ImmunotherapyCharlotte Blanc, Sophie Hans, Thi Tran, et al.
Oncoimmunology|June 22, 2012
Trial watch: Chemotherapy with immunogenic cell death inducersErika Vacchelli, Lorenzo Galluzzi, Wolf Hervé Fridman, et al.
Oncoimmunology|June 14, 2013
Trial Watch: Adoptive cell transfer for anticancer immunotherapyErika Vacchelli, Alexander Eggermont, Wolf Hervé Fridman, et al.
Pageof 23